# A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

> **NCT07176962** · — · RECRUITING · sponsor: **Yingbin Liu, MD, PhD, FACS** · enrollment: 1800 (estimated)

## Conditions studied

- Gall Bladder Cancer
- Intrahepatic Cholangiocarcinoma (Icc)
- Extrahepatic Cholangiocarcinoma
- Hilar Cholangiocarcinoma
- Billiary Track Cancer
- ctDNA

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07176962
- **Lead sponsor:** Yingbin Liu, MD, PhD, FACS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2026-03-21
- **Final completion:** 2026-05-01
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07176962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07176962, "A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07176962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*